Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1954 1
1955 2
1956 1
1957 1
1958 1
1959 4
1960 1
1961 2
1962 1
1963 2
1964 1
1966 1
1967 2
1968 1
1970 3
1972 1
1973 1
1974 2
1975 3
1976 3
1977 3
1978 4
1979 1
1980 3
1981 4
1983 2
1984 5
1985 4
1986 6
1987 3
1988 5
1989 4
1990 11
1991 6
1992 7
1993 8
1994 11
1995 9
1996 5
1997 10
1998 8
1999 7
2000 9
2001 11
2002 4
2003 3
2004 7
2005 4
2006 12
2007 8
2008 6
2009 8
2010 4
2011 17
2012 11
2013 12
2014 6
2015 11
2016 11
2017 13
2018 18
2019 16
2020 12
2021 14
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

364 results
Results by year
Filters applied: . Clear all
Page 1
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).
Fukuoka S, Hara H, Takahashi N, Kojima T, Kawazoe A, Asayama M, Yoshii T, Kotani D, Tamura H, Mikamoto Y, Hirano N, Wakabayashi M, Nomura S, Sato A, Kuwata T, Togashi Y, Nishikawa H, Shitara K. Fukuoka S, et al. Among authors: hirano n. J Clin Oncol. 2020 Jun 20;38(18):2053-2061. doi: 10.1200/JCO.19.03296. Epub 2020 Apr 28. J Clin Oncol. 2020. PMID: 32343640 Clinical Trial.
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2.
Nguyen LT, Saibil SD, Sotov V, Le MX, Khoja L, Ghazarian D, Bonilla L, Majeed H, Hogg D, Joshua AM, Crump M, Franke N, Spreafico A, Hansen A, Al-Habeeb A, Leong W, Easson A, Reedijk M, Goldstein DP, McCready D, Yasufuku K, Waddell T, Cypel M, Pierre A, Zhang B, Boross-Harmer S, Cipollone J, Nelles M, Scheid E, Fyrsta M, Lo CS, Nie J, Yam JY, Yen PH, Gray D, Motta V, Elford AR, DeLuca S, Wang L, Effendi S, Ellenchery R, Hirano N, Ohashi PS, Butler MO. Nguyen LT, et al. Among authors: hirano n. Cancer Immunol Immunother. 2019 May;68(5):773-785. doi: 10.1007/s00262-019-02307-x. Epub 2019 Feb 11. Cancer Immunol Immunother. 2019. PMID: 30747243 Clinical Trial.
Diagnostic strategies for early pancreatic cancer.
Hanada K, Okazaki A, Hirano N, Izumi Y, Teraoka Y, Ikemoto J, Kanemitsu K, Hino F, Fukuda T, Yonehara S. Hanada K, et al. Among authors: hirano n. J Gastroenterol. 2015 Feb;50(2):147-54. doi: 10.1007/s00535-014-1026-z. Epub 2014 Dec 14. J Gastroenterol. 2015. PMID: 25501287 Review.
Psoriasis with short stature improved by adalimumab.
Hirano N, Houbara R, Korematsu S, Hatano Y, Ihara K. Hirano N, et al. Pediatr Dermatol. 2021 Sep;38(5):1379-1381. doi: 10.1111/pde.14784. Epub 2021 Sep 13. Pediatr Dermatol. 2021. PMID: 34514629
Effective screening for early diagnosis of pancreatic cancer.
Hanada K, Okazaki A, Hirano N, Izumi Y, Minami T, Ikemoto J, Kanemitsu K, Hino F. Hanada K, et al. Among authors: hirano n. Best Pract Res Clin Gastroenterol. 2015 Dec;29(6):929-39. doi: 10.1016/j.bpg.2015.09.017. Epub 2015 Sep 26. Best Pract Res Clin Gastroenterol. 2015. PMID: 26651254 Review.
Two Weeks' Notice from Allogeneic Sources.
Anczurowski M, Hirano N. Anczurowski M, et al. Among authors: hirano n. Clin Cancer Res. 2018 Nov 1;24(21):5195-5197. doi: 10.1158/1078-0432.CCR-18-1552. Epub 2018 Jun 25. Clin Cancer Res. 2018. PMID: 29941482
364 results